Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused […]
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
Data highlights socio-demographic and clinical disparities to help raise awareness of health inequities and inform future treatment planningReal-world data from […]
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
LEXINGTON, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
Ares Genetics nominated for the 40th Austrian Innovation Award by Federal Ministry for Digital and Economic AffairsARESupa – Universal Pathogenome […]
ICU Medical, Inc. to Present at Morgan Stanley 18th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and […]
Axovant Announces First Parkinson’s Disease Gene Therapy R&D Day and Participation in Upcoming September Conferences”
– Parkinson’s Disease R&D Day to be hosted by Gavin Corcoran, MD, Chief R&D Officer, on October 30th, […]
Kitov Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients
TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class […]
Medigus: Fortune 500 Multinational Healthcare Corporation’s Adds ScoutCam to its Approved Supplier List
OMER, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and […]
Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS™) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury
NEWTOWN, Pa., Sept. 08, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in September
NESS ZIONA, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage dermatology company focused on […]
